Response to Stuyt and Hilderbrand re: “Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series” ( J Altern Complement Med 2020;26:349–350. DOI: 10.1089/acm.2019.0380)
Restricted accessLetterFirst published online April, 2020
Response to Stuyt and Hilderbrand re: “Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series” ( J Altern Complement Med 2020;26:349–350. DOI: 10.1089/acm.2019.0380)
DasRK, KambojSK, RamadasM, et al.Cannabidiol enhances consolidation of explicit fear extinction in humans. Psychopharmacology (Berl), 2013; 226:781–792.
2.
OrsoliniL, ChiappiniS, VolpeU, et al.Use of medicinal cannabis and synthetic cannabinoids in post-traumatic stress disorder (PTSD): A systematic review. Medicina (Kaunas), 2019; 55. DOI: 10.3390/medicina55090525. Review.
3.
BitencourtRM, TakahashiRN. Cannabidiol as a therapeutic alternative for post-traumatic stress disorder: From bench research to confirmation in human trials. Front Neurosci, 2018; 12:502.
4.
HindochaC, CousijnJ, RallM, BloomfieldMAP. The effectiveness of cannabinoids in the treatment of posttraumatic stress disorder (PTSD): A systematic review. J Dual Diagn, 2019:1–20. [Epub ahead of print]; DOI: 10.1080/15504263.2019.1652380.
